Audiometry identifies genetic loci linked to hearing loss
-
By
-
Andrea Surnit
-
November 13, 2026
-
5 min
By
Andrea Surnit
November 13, 2026
Five reproducible MASLD subtypes showed distinct genetic profiles and patterns of metabolic comorbidity and disease progression.
September 10, 2026
Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.
June 26, 2026
Combining IL-17 with TNF-alpha showed strong discrimination between carious lesions and healthy controls, but performance was more modest against gingival inflammation.
September 9, 2026